Diabetes mellitus and ovarian cancer: Intersecting pathways and clinical outcomes

doi:10.5306/wjco.v17.i5.117365

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 5

This Article

(0) (0) (0) (58)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Clin Oncol. May 24, 2026; 17(5): 117365
Published online May 24, 2026. doi: 10.5306/wjco.v17.i5.117365

Open in New Tab Full Size Figure Download Figure

Figure 1 Mechanistic pathways linking diabetes mellitus to ovarian carcinogenesis. IGF: Insulin-like growth factor; ROS: Reactive oxygen species; AGE: Advanced glycation end-products.

Open in New Tab Full Size Figure Download Figure

Figure 2 Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors: Disrupting diabetes-ovarian cancer link. GLP-1: Glucagon-like peptide-1; IGF: Insulin-like growth factor; SGLT2: Sodium-glucose cotransporter-2.

Citation: Patel T, Ali SK, Jawad Y, Haddad SH, Al Masri LM, Rimawi A, Alraeesi RA, Alkaabi HS, Farhan M, Zahid M, Ahmad M, Choudhary N, Nazir MH, Awosika A. Diabetes mellitus and ovarian cancer: Intersecting pathways and clinical outcomes. World J Clin Oncol 2026; 17(5): 117365
URL: https://www.wjgnet.com/2218-4333/full/v17/i5/117365.htm
DOI: https://dx.doi.org/10.5306/wjco.v17.i5.117365

Patel T, Ali SK, Jawad Y, Haddad SH, Al Masri LM, Rimawi A, Alraeesi RA, Alkaabi HS, Farhan M, Zahid M, Ahmad M, Choudhary N, Nazir MH, Awosika A. Diabetes mellitus and ovarian cancer: Intersecting pathways and clinical outcomes. World J Clin Oncol 2026; 17(5): 117365 [DOI: 10.5306/wjco.v17.i5.117365]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.